Value Gene Therapy Deals Like Top-Tier VCs
Get instant, data-driven licensing valuations with our proprietary calculator used by leading biotech dealmakers.
Calculate NowMarket-Leading Accuracy
Our algorithm factors in the current 12% valuation premium and cooling market conditions, delivering valuations within 15% of actual deal terms.
Lightning-Fast Results
Skip weeks of manual analysis. Generate comprehensive deal scenarios in under 60 seconds with our advanced modeling engine.
Real-Time Market Data
Access live benchmarks from $2.5B+ in gene therapy deals, including Phase 2 upfront ranges of $60M-$250M and total deal structures.
$2.5B+
Deal Value Analyzed
300+
Gene Therapy Transactions
15%
Accuracy vs Actual Terms
60 sec
Average Calculation Time
How It Works
Input Deal Parameters
Enter your gene therapy's development stage, target indication, and key clinical milestones.
Apply Market Conditions
Our algorithm automatically adjusts for current market dynamics and manufacturing risk factors.
Generate Deal Structure
Receive detailed upfront, milestone, and royalty recommendations with comparable transaction data.
Frequently Asked Questions
How does the calculator account for current market cooling?
What gene therapy modalities are covered?
How current is the deal benchmark data?
Can I model different deal structures?
Ready to Calculate Your Deal Terms?
Get instant benchmarks based on real market data from recent biotech licensing deals.
Start Calculating